Medtronic Renal Denervation System Provides Durable Blood Pressure Benefits In Longest Trial To Date
This article was originally published in The Gray Sheet
Executive Summary
The latest results from Medtronic’s SYMPLICITY HTN-2 trial show that patients treated for severe hypertension with the company’s Symplicity radio frequency renal denervation system showed a sustained reduction in blood pressure. The firm also announced the start of a renal denervation trial in patients with moderate hypertension.